Publicaciones en colaboración con investigadores/as de University of Texas MD Anderson Cancer Center (16)

2023

  1. Global Cancer Surgery: pragmatic solutions to improve cancer surgery outcomes worldwide

    The Lancet Oncology, Vol. 24, Núm. 12, pp. e472-e518

2022

  1. Higher Adherence to ERAS Society® Recommendations is Associated with Shorter Hospital Stay Without an Increase in Postoperative Complications or Readmissions in Bariatric Surgery: the Association Between Use of Enhanced Recovery After Surgery Protocols and Postoperative Complications after Bariatric Surgery (POWER 3) Multicenter Observational Study

    Obesity surgery, Vol. 32, Núm. 4, pp. 1289-1299

2021

  1. Breast conservation and axillary management after primary systemic therapy in patients with early-stage breast cancer: the Lucerne toolbox

    The Lancet Oncology, Vol. 22, Núm. 1, pp. e18-e28

  2. Elective Cancer Surgery in COVID-19-Free Surgical Pathways during the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study

    Journal of Clinical Oncology, Vol. 39, Núm. 1, pp. 66-78

  3. Evaluation of multiple transcriptomic gene risk signatures in male breast cancer

    npj Breast Cancer, Vol. 7, Núm. 1

  4. The ESSO core curriculum committee update on surgical oncology

    European Journal of Surgical Oncology, Vol. 47, Núm. 11, pp. e1-e30

2020

  1. Oncoplastic Breast Surgery Techniques for the General Surgeon

    Springer International Publishing, pp. 1-635

  2. Preface

    Oncoplastic Breast Surgery Techniques for the General Surgeon

2019

  1. European Society of Surgical Oncology's strategy for clinical research: Paving the way for a culture of research in cancer surgery

    European Journal of Surgical Oncology, Vol. 45, Núm. 9, pp. 1515-1519

2018

  1. Characterization of male breast cancer: Results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program

    Annals of Oncology, Vol. 29, Núm. 2, pp. 405-417

  2. Risk factors for locoregional disease recurrence after breast-conserving therapy in patients with breast cancer treated with neoadjuvant chemotherapy: An international collaboration and individual patient meta-analysis

    Cancer, Vol. 124, Núm. 14, pp. 2923-2930

2016

  1. 70-Gene signature as an aid to treatment decisions in early-stage breast cancer

    New England Journal of Medicine, Vol. 375, Núm. 8, pp. 717-729

2010

  1. Sequential administration of dose-dense epirubicin/cyclophosphamide followed by docetaxel/capecitabine for patients with HER2-negative and locally advanced or node-positive breast cancer

    Cancer Chemotherapy and Pharmacology, Vol. 65, Núm. 3, pp. 457-465

2009

  1. Ileal orthotopic neobladder after pelvic exenteration for cervical cancer

    Gynecologic Oncology, Vol. 113, Núm. 1, pp. 47-51

2000

  1. Impact of multicentricity on clinical outcome in patients with T1-2, N0-1, M0 breast cancer

    Annals of Surgical Oncology, Vol. 7, Núm. 8, pp. 581-587

  2. Role of specimen radiography in patients treated with skin-sparing mastectomy for ductal carcinoma in situ of the breast

    Annals of Surgical Oncology, Vol. 7, Núm. 7, pp. 544-548